Literature DB >> 8631781

Synergistic induction of osteocalcin gene expression: identification of a bipartite element conferring fibroblast growth factor 2 and cyclic AMP responsiveness in the rat osteocalcin promoter.

J M Boudreaux1, D A Towler.   

Abstract

Fibroblast growth factors (FGFs) are important regulators of calvarial osteoblast growth and differentiation. We have studied the regulation of the osteoblast-specific gene osteocalcin (OC) by FGF2 in phenotypically immature MC3T3-E1 calvarial osteoblastic cells. FGF2 markedly induces OC mRNA accumulation in MC3T3-E1 cells in the presence of forskolin (FSK). Similarly, OC promoter activity (luciferase reporter) is up-regulated 6-10-fold by FGF2/FSK or by FGF2/8-bromo cyclic AMP. Half-maximal induction of OC promoter activity occurs at 1 nM FGF2. By 5' deletion analysis and dinucleotide point mutations, we map one component of this FGF2/FSK response to a GCAGTCA motif in the region -144 to -138 relative to the OC transcription initiation site. The OC promoter region -154 to -90 confers FGF2/FSK responsiveness on the Rous sarcoma virus minimal promoter. By 3' and internal deletion analyses, the region between -90 to -99 is also found to be necessary for FGF2/FSK synergy (encodes a PuGGTCA motif previously identified as a component of FSK induction). A DNA binding activity that recognizes the region -148 to -125 of the rat OC promoter is induced in crude nuclear extracts from MC3T3-E1 cells treated with FGF2 or FGF2/FSK. This binding activity is sequence-specific and does not recognize the TCAGTCA DNA cognate of AP1. Members of the ATF, Fos, and Jun family are not immunologically detected in this inducible DNA binding activity. However, transient co-expression of ATF3 but not ATF2 selectively attenuates the FGF2 component of induction. Thus, a novel FGF2-regulated DNA-protein interaction in the OC promoter participates in the transcriptional control of OC expression by FGF and cyclic AMP in MC3T3-E1 calvarial osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631781     DOI: 10.1074/jbc.271.13.7508

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  Synergistic action of fibroblast growth factor-2 and transforming growth factor-beta1 enhances bioprinted human neocartilage formation.

Authors:  Xiaofeng Cui; Kurt Breitenkamp; Martin Lotz; Darryl D'Lima
Journal:  Biotechnol Bioeng       Date:  2012-04-08       Impact factor: 4.530

3.  Msx2 exerts bone anabolism via canonical Wnt signaling.

Authors:  Su-Li Cheng; Jian-Su Shao; Jun Cai; Oscar L Sierra; Dwight A Towler
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

4.  Runx2 trans-activation mediated by the MSX2-interacting nuclear target requires homeodomain interacting protein kinase-3.

Authors:  Oscar L Sierra; Dwight A Towler
Journal:  Mol Endocrinol       Date:  2010-05-19

Review 5.  The osteocalcin gene: a model for multiple parameters of skeletal-specific transcriptional control.

Authors:  G S Stein; J B Lian; A J van Wijnen; J L Stein
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

6.  PTH/PTHrP Receptor Signaling Restricts Arterial Fibrosis in Diabetic LDLR-/- Mice by Inhibiting Myocardin-Related Transcription Factor Relays.

Authors:  Abraham Behrmann; Dalian Zhong; Li Li; Su-Li Cheng; Megan Mead; Bindu Ramachandran; Parastoo Sabaeifard; Mohammad Goodarzi; Andrew Lemoff; Henry M Kronenberg; Dwight A Towler
Journal:  Circ Res       Date:  2020-03-11       Impact factor: 17.367

7.  Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.

Authors:  Brian K Yeh; Anna V Eliseenkova; Alexander N Plotnikov; David Green; Jared Pinnell; Tulay Polat; Amel Gritli-Linde; Robert J Linhardt; Moosa Mohammadi
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

8.  Regulation of mRNA expression of matrix extracellular phosphoglycoprotein (MEPE)/ osteoblast/osteocyte factor 45 (OF45) by fibroblast growth factor 2 in cultures of rat bone marrow-derived osteoblastic cells.

Authors:  Gui Xia Zhang; Morimichi Mizuno; Kiyomi Tsuji; Masato Tamura
Journal:  Endocrine       Date:  2004-06       Impact factor: 3.633

9.  Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation.

Authors:  A J Brown; M Alicknavitch; S S D'Souza; T Daikoku; C B Kirn-Safran; D Marchetti; D D Carson; M C Farach-Carson
Journal:  Bone       Date:  2008-06-06       Impact factor: 4.398

10.  Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone.

Authors:  Shibing Yu; Renny T Franceschi; Min Luo; Jie Fan; Di Jiang; Huiling Cao; Tae-Geon Kwon; Yumei Lai; Jian Zhang; Kenneth Patrene; Kurt Hankenson; G David Roodman; Guozhi Xiao
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.